Health Care & Life Sciences » Biotechnology | Zhejiang Wolwo Bio Pharmaceutical Co. Ltd.

Zhejiang Wolwo Bio Pharmaceutical Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
103,336.40
335,474.60
371,807.10
407,148.30
486,982.20
576
Total Accounts Receivable
77,794.20
98,904.10
102,011.30
116,287.40
145,141.50
173
Inventories
7,967.50
11,913.30
9,155.00
14,040.50
19,827.40
23
Other Current Assets
5,985.80
626.90
1,305.90
1,738.40
4,546.10
9
Total Current Assets
195,083.80
446,918.90
484,279.40
539,214.60
656,497.20
782
Net Property, Plant & Equipment
48,431.10
60,282.20
96,971.10
118,530.20
123,563.80
138
Total Investments and Advances
-
-
-
-
13,000.00
13
Intangible Assets
19,404.30
21,785.60
27,784.00
36,760.10
53,140.60
123
Other Assets
-
1,015.10
1,176.00
708.50
389.20
-
Total Assets
263,954.90
531,306.80
611,487.50
696,894.60
848,311.20
1,058
Accounts Payable
597.00
999.00
598.40
1,027.10
1,380.30
Income Tax Payable
3,989.50
7,249.40
4,159.70
3,067.30
14,708.80
Other Current Liabilities
7,449.00
7,954.50
19,870.60
32,370.40
26,110.90
Total Current Liabilities
12,035.50
16,202.90
24,628.70
36,464.70
42,200.10
Deferred Taxes
1,035.70
1,305.00
1,277.20
1,681.40
1,720.40
Total Liabilities
12,035.50
16,202.90
24,628.70
36,464.70
42,200.10
Common Equity (Total)
251,909.90
513,550.20
582,913.50
655,576.70
801,257.90
Total Shareholders' Equity
251,909.90
513,550.20
582,913.50
655,576.70
801,257.90
Total Equity
251,919.40
513,553.60
582,913.50
655,576.70
801,257.90
Liabilities & Shareholders' Equity
263,954.90
531,306.80
611,487.50
696,894.60
848,311.20
Accumulated Minority Interest
9.60
3.50
-
-
-
Non-Equity Reserves
-
1,550.30
3,945.40
4,853.20
4,853.20

About Zhejiang Wolwo Bio Pharmaceutical Co.

View Profile
Address
No. 636 Zhiyuan North Road
Huzhou Zhejiang 313299
China
Employees -
Website http://www.wolwobiotech.com
Updated 07/08/2019
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of bio-pharmaceutical products. It primarily focuses on the diagnosis and treatment for allergic diseases. The company was founded on September 19, 2002 and is headquartered in Huzhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.